Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8, September 2006

IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE

  • Emma J. O’Neill

      Affiliations

    • School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, Belfield, Dublin 4, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1716 6025; fax: +353 1716 6023.
    • ,
  • Michael J. Day

      Affiliations

    • Division of Veterinary Pathology, Infection and Immunity, Department of Clinical Veterinary Science, University of Bristol, Langford House, Langford, BS40 5DU, UK
    • ,
  • David C. Wraith

      Affiliations

    • Department of Cellular and Molecular Medicine, University of Bristol, Medical School, University Walk, Bristol BS8 1TD, UK

Received 24 February 2006; received in revised form 23 May 2006; accepted 26 May 2006. published online 27 July 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-5728(06)00210-4

doi:10.1016/j.jneuroim.2006.05.030

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8, September 2006

Article Tools

* Image Usage & Resolution